Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,220,484 papers from all fields of science
Search
Sign In
Create Free Account
Xenical
Known as:
Hoffmann-La Roche brand of orlistat
, Roche brand of orlistat
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
Broader (1)
orlistat
orlistat 120 MG Oral Capsule [Xenical]
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2016
Review
2016
Medical management of obesity in Scandinavia 2016
S. Tonstad
,
S. Rössner
,
A. Rissanen
,
A. Astrup
2016
Corpus ID: 53048278
Review
2015
Review
2015
Anti-Obesity Drug Orlistat (Xenical) Is a Novel Antitumor Medication
L. Azadbakht
,
Zahra Jamali-Gojani
,
M. Heidari-Beni
2015
Corpus ID: 56761166
Background: Orlistat (Xenical) is an approved medication for treating obesity. Recent studies suggested a new application for…
Expand
2010
2010
Investigation of Orlistat effects on PXR activation and CYP3A4 expression in primary human hepatocytes and human intestinal LS174T cells.
A. Novotná
,
Aneta Dořičáková
,
R. Vrzal
,
P. Maurel
,
P. Pávek
,
Z. Dvořák
European Journal of Pharmaceutical Sciences
2010
Corpus ID: 21433907
2010
2010
Pharmaceutical Quality of Nine Generic Orlistat Products Compared with Xenical®
Peter W. Taylor
,
I. Arnet
,
A. Fischer
,
Iain N. Simpson
Obesity Facts
2010
Corpus ID: 1669234
Objective: To compare the pharmaceutical quality of Xenical (chemically produced orlistat) with nine generic products, each…
Expand
2008
2008
Evaluation of Urinary Oxalate Levels in Patients Receiving Gastrointestinal Lipase Inhibitor
K. Sarıca
,
E. Akarsu
,
S. Erturhan
,
F. Yaǵci
,
Ş. Aktaran
,
B. Altay
Obesity
2008
Corpus ID: 205525184
Objective: The purpose of this study was to examine the possible effects of a gastrointestinal lipase inhibitor “Orlistat…
Expand
Review
2000
Review
2000
Orlistat (Xenical) in the management of obesity.
J. Cheah
Annals of the Academy of Medicine, Singapore
2000
Corpus ID: 39124457
The term “obesity” implies an excess of adipose tissue (fat) and excess adiposity is a health risk. In most cases it develops in…
Expand
1999
1999
Effect of orlistat on blood cyclosporin concentration in an obese heart transplant patient
Herbert Nägele
,
B. Petersen
,
U. Bonacker
,
W. Rödiger
European Journal of Clinical Pharmacology
1999
Corpus ID: 25042161
AbstractObjective: We detected markedly decreased cyclosporin blood levels in a heart-transplanted patient after the…
Expand
Review
1999
Review
1999
Chapter 31. To Market, To Market - 1998
B. Gaudillière
1999
Corpus ID: 57767919
Review
1999
Review
1999
Orlistat (Xenical).
A. M. MacConnachie
Intensive & Critical Care Nursing
1999
Corpus ID: 21682828
The introduction of orlistat (Roche, UK) at the end of last year received considerable media coverage and was heralded in some…
Expand
Review
1998
Review
1998
Modern medical management of obesity: the role of pharmaceutical intervention.
L. Aronne
Journal of the American Dietetic Association
1998
Corpus ID: 36015906
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE